FUSIONMRD Trademark

Trademark Overview

On Monday, November 17, 2025, a trademark application was filed for FUSIONMRD with the United States Patent and Trademark Office. The USPTO has given the FUSIONMRD trademark a serial number of 99500737. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 17, 2025. This trademark is owned by Pairidex Inc.. The FUSIONMRD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Molecular diagnostic services for detecting leukemia; Medical diagnostic services; Molecular diagnostic services for detecting diseases; Molecular diagnostic services for detecting cancer
fusionmrd

General Information

Serial Number99500737
Word MarkFUSIONMRD
Filing DateMonday, November 17, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, November 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMolecular diagnostic services for detecting leukemia; Medical diagnostic services; Molecular diagnostic services for detecting diseases; Molecular diagnostic services for detecting cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 17, 2025
Primary Code044
First Use Anywhere DateWednesday, October 22, 2025
First Use In Commerce DateWednesday, October 22, 2025

Trademark Owner History

Party NamePairidex Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63110

Trademark Events

Event DateEvent Description
Monday, November 17, 2025NEW APPLICATION ENTERED
Monday, November 17, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

fusionmrd services diagnostic molecular detecting cancer diseases medical leukemia